How to buy bulk generic medicines from India: a working guide for importers.

You have a SKU list and a target landed cost. Perhaps a wholesale licence at home, a hospital group waiting on stock, or a tender deadline that assumes Indian pricing. What you do not yet have is a clear picture of how buying in bulk from India actually works: who sells what, why minimum quantities move around, which documents your regulator and your customs broker will demand, and where the cost really lands once the container clears. This guide walks through that process in the order a first order actually happens.

It is written by M Care Exports, an ISO 9001:2015 certified, CDSCO-licensed merchant-exporter that has supplied importers, wholesalers, hospital groups and tender desks abroad since 2003. We source from WHO-GMP certified Indian manufacturing sites and we do not manufacture ourselves, so we have no factory to flatter. Where a manufacturer is the better counterparty for your order, this guide says so.

Start with the SKU list, not the supplier search.

Most first-time importers begin by searching for a bulk pharmaceutical supplier in India and end up drowning in near-identical websites. Reverse it. Write the SKU list first, because the list determines which suppliers are even relevant. For each line, pin down five things:

• Molecule, strength and dosage form. Amoxicillin 500 mg capsules and amoxicillin 250 mg dispersible tablets are different products with different sources and different minimums.
• Pack presentation. Blister or bulk pot, hospital pack or retail pack, and whose artwork goes on the carton.
• Annual volume and call-off pattern. One container a year and a monthly replenishment order need different supply structures.
• Registration status in your market. Is the product already registered to an importer of record, or does it need a new registration built on the manufacturer's dossier?
• Cold-chain requirement. Flag every 2 to 8 degree line now, not at booking.

Split the list into lines that are ready to ship against an existing registration and lines that need a dossier and registration step first. The second group is a project, not a purchase order, and it is where CTD dossier preparation support matters more than price.

Manufacturer or merchant-exporter: how Indian supply is structured.

Two kinds of company will quote your list. A manufacturer-exporter owns the plant. It gives you factory-gate pricing on its own lines, but its catalogue stops at what its plant makes, and a twenty-line list can mean six separate factory relationships, six document trails and six payments. A merchant-exporter, sometimes described as an Indian pharmaceutical wholesaler for import, does not manufacture. It holds its own wholesale drug licences and export registrations, sources each line from the WHO-GMP certified manufacturer best placed to make it, and consolidates the goods, the documents and the payment into one counterparty.

Neither model is inherently better. Single-molecule, full-container, repeat volume often sits naturally with a manufacturer. Mixed baskets, tender lists and orders where documentation is the bottleneck sit naturally with a merchant-exporter. M Care is a merchant-exporter: ISO 9001:2015 is our own certificate as a trading entity, while WHO-GMP always belongs to the manufacturing site, which we name on every quote. The full commercial terms of that model are set out on our bulk supply and wholesale page.

How MOQs and batch sizes actually work in Indian pharma.

Ask any pharmaceutical exporter in India about MOQ and you will get answers that seem inconsistent. They are not arbitrary. Three drivers set the real minimum on any line:

1. Batch size. A manufacturing line produces in batches, and the plant will not run a fraction of a batch for one buyer. If your order is smaller than the batch, you either take an allocation from a batch being shared across buyers or you wait for one.
2. Artwork and printed packaging. The moment you want your own brand, your own leaflet or your market's labelling language, the printer's minimum run for cartons and foils becomes part of your MOQ. Generic export livery from existing stock can go lower.
3. Shelf life. Buying from an existing batch means accepting the shelf life that batch has left. If your tender or your regulator demands a high minimum remaining shelf life, you are effectively ordering a fresh batch, and the fresh-batch minimum applies.

This is why an honest supplier will not publish one blanket MOQ, and why we do not invent one here. The workable minimum is confirmed molecule by molecule once the strength, pack, artwork and shelf-life requirement are known. Send the SKU list and ask; a supplier who quotes a minimum before asking those questions is guessing.

Samples, COAs and pre-shipment verification.

Before the first commercial order, verify the product, not just the paperwork. Ask for samples of the exact presentation you will buy, from the manufacturing site that will supply you, together with the batch Certificate of Analysis for those samples. The CoA should test against a stated pharmacopoeia, typically BP, USP or IP, and the batch number on the certificate must match the batch in your hand.

For a first shipment, two further controls are worth their cost. First, an independent retest of retained samples at an accredited laboratory in your own market, with acceptance made conditional on the result. Second, pre-shipment inspection or photographs of the packed goods, cartons and shipper labelling before the container is sealed, so a labelling error is caught in India rather than at your port. From the second or third shipment onwards, most buyers relax to document review plus periodic retesting.

Verifying the company behind the goods is a separate discipline with its own public registers, and we have covered it in depth in our guide to verifying an Indian pharmaceutical exporter before you pay. Run that workflow before the deposit, not after.

The document pack: what must travel with the goods.

In cross-border pharma, the shipment is only as usable as its paperwork. Agree the full document set on the proforma, before production, because some documents take longer to obtain than the goods take to make. The core pack:

• Certificate of Pharmaceutical Product (CoPP). Issued in India by CDSCO under the WHO certification scheme, naming the product and the manufacturing site. Many importing regulators, particularly across Africa, Asia, Latin America and the GCC, require it for product registration, and many markets require it legalised or apostilled.
• WHO-GMP certificate of the manufacturing site. The manufacturer's credential, never the trader's. The site named on it must match the CoPP and the CoA.
• Batch Certificate of Analysis for every batch shipped, against the agreed pharmacopoeia.
• Commercial invoice and packing list, with the exporting entity's name matching its export registrations and your payment instructions.
• Certificate of Origin, which your customs authority uses for tariff treatment.
• Insurance certificate where the Incoterm makes the seller responsible for cover.
• Transport document: bill of lading for sea, air waybill for air.

Insist on pre-alert copies of the full set before dispatch. A missing or mismatched document discovered while the container sits at your port is one of the most common, and most avoidable, cost overruns in this trade.

Incoterms and payment terms used in practice.

Indian pharma exports run overwhelmingly on a handful of Incoterms 2020 rules. FOB suits buyers with their own freight contracts and forwarders: you take over at the Indian port and control the lane. CIF and CIP put freight and insurance on the exporter, which simplifies a first order; the difference worth knowing is that Incoterms 2020 requires only minimum insurance cover under CIF but all-risks level cover under CIP, which is why careful pharmaceutical buyers often prefer CIP when the seller arranges cover. EXW is best avoided by new importers, since it leaves Indian export clearance ambiguously on your side of the line.

On payment, the two working instruments are the letter of credit, at sight or usance, and telegraphic transfer staged against milestones, typically an advance with the balance against shipping documents. An LC costs bank fees but protects both sides on a first transaction; staged TT is cheaper and faster once trust is established. Whatever the split, pay only against documents, and only to a bank account whose holder name matches the exporting entity. We have written a fuller treatment in our guide to Incoterms and payment terms for pharma imports from India.

Cold chain and shipping lanes: air or sea.

Tablets and capsules with standard storage conditions move happily by sea, and for container-scale volume, sea freight is usually the economic answer. The trade-off is time: a longer transit consumes shelf life and stretches your reorder cycle, so sea freight suits products with shelf-life headroom and a forecastable demand pattern. Air freight costs more per kilogram but compresses transit to days, which matters for high-value oncology lines, urgent tender deliveries and any first order you want to evaluate quickly.

Cold-chain lines change the calculation. A 2 to 8 degree product needs qualified packaging, calibrated data loggers in every shipment, and a lane that has actually been assessed for summer and winter conditions, not just a polystyrene box and hope. Air is the default for smaller cold-chain consignments; reefer sea containers become viable at scale. Whichever lane you use, agree in writing what happens on a temperature excursion: who reviews the logger data, within what time, and what triggers rejection and replacement. Our cold-chain validation service page describes how we qualify and monitor these lanes as the exporter.

Think in landed cost, not unit price.

The cheapest FOB quote is frequently not the cheapest medicine on your shelf. Landed cost is the number that matters, and it stacks up like this: the goods at the agreed Incoterm, plus freight and insurance where they sit on your side, plus customs duty and any import VAT or equivalent tax in your market, plus clearance and handling charges, plus onward transport and storage, plus any local retesting your regulator requires, plus the amortised cost of registration if you funded the dossier. Duty and tax rates vary by country and by tariff classification, so build your own model rather than borrowing percentages from a forum.

Two practical rules keep comparisons honest. First, compare quotes on the same Incoterm, or convert them before comparing; an FOB price against a CIF price tells you nothing. Second, price the paperwork: a supplier whose document pack clears customs first time is cheaper in practice than one whose errors cost you demurrage, even at a higher unit price. Importers who buy bulk generic medicines from India on landed cost rather than headline price tend to build repeat supply relationships; those who chase the headline number tend to rotate suppliers and pay for the education each time.

From first container to recurring supply.

The economics of importing medicines from India improve sharply from the second order onwards, but only if the relationship is built deliberately. Start with a trial order sized to prove the process rather than maximise the discount. When it lands, score the supplier on the things that predict the next five shipments: did the documents match the goods, did pre-alerts arrive before dispatch, did the shelf life match the proforma, did questions get answered by a named person.

Then convert the relationship to a rhythm. Share a rolling forecast so batches can be planned rather than begged for, agree a minimum remaining shelf life as a standing term, fix a review cadence for pricing instead of renegotiating every order, and keep one named contact on each side. If you are consolidating multiple molecules, ask your merchant-exporter to hold the manufacturer mix stable and to notify you before any source change, since a new site means new documents for your regulator. A good supplier will offer this discipline unprompted; a mediocre one will resist being measured. That difference shows up long before any quality problem does.

FAQ

What is the minimum order quantity when importing medicines from India?

There is no universal MOQ. The minimum on any line is set by the manufacturer's batch size, the printed-packaging run if you need your own artwork, and the shelf life you require. Generic-livery stock from an existing batch can go lower; a fresh batch with your artwork means the full batch minimum. Send the SKU list with strengths and packs and ask for the workable minimum per line.

Can I buy bulk generic medicines from India if the product is not yet registered in my country?

Usually yes, but registration comes first. Your regulator will typically want the manufacturer's CTD dossier, a CoPP issued by CDSCO, and the WHO-GMP certificate of the manufacturing site before granting a licence. A capable exporter supports that filing and tells you which lines are already registered in your market and can ship sooner. Treat unregistered lines as a project with a timeline, not a purchase order.

Should I import from a manufacturer or from an Indian pharmaceutical wholesaler?

It depends on your basket. A manufacturer suits single-molecule, full-container, repeat volume on its own lines at factory pricing. A merchant-exporter or wholesaler consolidates several manufacturers into one shipment, one document pack and one payment, which suits mixed SKU lists, tenders and buyers who want a single accountable counterparty. Many importers use both models for different order types.

Which payment terms are normal for a first order from an Indian exporter?

A letter of credit, at sight or usance, or a telegraphic transfer staged against milestones, with the balance released against shipping documents. An LC costs bank fees but protects both sides on a first transaction. Whatever the structure, pay only against documents and confirm the bank account holder name matches the exporting entity exactly. Demands for full payment in advance from a new counterparty deserve scepticism.

How long does it take to import medicines from India?

It depends on three things: whether the product is registered in your market or needs a dossier filed first, whether the goods ship from an existing batch or a fresh production run, and whether you use air or sea freight. Registered lines from available stock move quickest; new registrations take months, driven by your regulator. Ask for a per-line timeline against your SKU list rather than a blanket promise.